![Laurie Myers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laurie Myers
Directeur des opérations chez
Cingulate Therapeutics LLC
Fortune : - $ au 31/05/2026
Profil
Laurie A. Myers currently works at Cingulate Therapeutics LLC, as Chief Operating Officer from 2017 and Cingulate Works, Inc., as Chief Operating Officer & Executive Vice President from 2017.
Dr. Myers also formerly worked at Fidia Pharma USA, Inc., as Head-Marketing from 2014 to 2017 and Cingulate, Inc., as Chief Operating Officer & Executive Vice President from 2018 to 2025.
Dr. Myers received her Masters Business Admin degree from St. Joseph's University, undergraduate degree and graduate degree from the University of Scranton, doctorate degree from Ernest Mario School of Pharmacy, and doctorate degree from New Jersey Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CINGULATE, INC. -.--% | 18/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Laurie Myers
| Sociétés | Poste | Début |
|---|---|---|
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Directeur des opérations | 01/11/2017 |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Directeur des opérations | 01/04/2017 |
Anciens postes connus de Laurie Myers
| Sociétés | Poste | Fin |
|---|---|---|
| CINGULATE INC. | Directeur des opérations | 07/08/2025 |
Fidia Pharma USA, Inc.
 Fidia Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Sales & Marketing | 01/11/2017 |
Formation de Laurie Myers
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Health Technology |
St. Joseph's University
 St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Scranton
 University of Scranton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fidia Pharma USA, Inc.
Fidia Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
New Jersey Medical School
 New Jersey Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernest Mario School of Pharmacy
 Ernest Mario School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Health Technology |
Cingulate, Inc.
 Cingulate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
